| Name | Title | Contact Details |
|---|
Scientist.com is the world's largest online research marketplace.
Renovacor is a preclinical gene therapy company developing a pipeline of innovative and proprietary AAV based gene therapies for BAG3 gene mutation-associated diseases in areas of high unmet medical need. Renovacor`s therapeutic focus is initially on cardiovascular disease, with a lead program in BAG3 mutation-associated dilated cardiomyopathy.
Solutions for isolation, recovery, and analysis of intact, individual rare cells. Single "cell sorter"
Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis.
Verseon is a Fremont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.